EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission - to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the body\'s immune system to prevent or treat disease. Their products target infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Their marketed product BioThrax? (Anthrax Vaccine Adsorbed) is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent BioSolutions Inc. has a market cap of $511.8 million; its shares were traded at around $16.91 with a P/E ratio of 13.1 and P/S ratio of 2.8.
Recent Trades of Emergent BioSolutions Inc. by CFO:
- Sell: CFO R Don Elsey sold 7,634 shares of EBS stock on 03/11/2009 at the average price of $19.68; the price of the stock has decreased by 14.08% since.
- Sell: CFO R Don Elsey sold 900 more shares of EBS stock on 03/10/2009 at the average price of $19.91; the price of the stock has decreased by 15.07% since.
- Sell: CFO R Don Elsey sold 5,800 more shares of EBS stock on 03/10/2009 at the average price of $19.27; the price of the stock has decreased by 12.25% since.
Recent Trades of Emergent BioSolutions Inc. by Directors and Officers:
- Sell: Director Zsolt Harsanyi sold 4,086 shares of EBS stock on 08/07/2009 at the average price of $15.45; the price of the stock has increased by 9.45% since.
- Sell: Director Zsolt Harsanyi sold 14,296 more shares of EBS stock on 07/30/2009 at the average price of $15.05; the price of the stock has increased by 12.36% since.
- Sell: Director Zsolt Harsanyi sold 20,694 more shares of EBS stock on 07/29/2009 at the average price of $15.01; the price of the stock has increased by 12.66% since.
- Sell: Director Zsolt Harsanyi sold 2,154 more shares of EBS stock on 06/18/2009 at the average price of $15; the price of the stock has increased by 12.73% since.
- Sell: Director Zsolt Harsanyi sold 1,927 more shares of EBS stock on 06/10/2009 at the average price of $15.06; the price of the stock has increased by 12.28% since.
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |